Barinthus Biotherapeutics PLC Sponsored ADR (BRNS)
(Delayed Data from NSDQ)
$1.89 USD
-0.11 (-5.50%)
Updated Jun 4, 2024 03:57 PM ET
After-Market: $1.99 +0.10 (5.29%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum D VGM
Brokerage Reports
Barinthus Biotherapeutics PLC Sponsored ADR [BRNS]
Reports for Purchase
Showing records 1 - 5 ( 5 total )
Company: Barinthus Biotherapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Barinthus Biotherapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
2023 Financial Results Reported; Reiterate Buy; Lowering PT to $8
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Barinthus Biotherapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Multiple Data Readouts Expected in 1H24; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Barinthus Biotherapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
New Partnership Inked on Vaccine Against MERS-CoV; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Barinthus Biotherapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Promising Interim Data from HBV Trials Presented; 3Q23 Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
|